6分钟步行试验在儿童慢性疾病中的应用
摘要
关键词
全文:
PDF参考
[1]中华医学会变态反应分会儿童过敏和哮喘学组,中华医学会儿科学分会呼吸学组肺功能协作组,中国人体健康科技促进会儿童变态反应专业委员会.心肺运动试验在儿童呼吸系统疾病中的应用专家共识[J].中华实用儿科临床杂志,2024,39(11):814-823.
[2]Qaasim Mian , Dax G Rumsey , Olaf Verschuren ,et al. Reference Values for the Six Minute Walk Test in Children with Juvenile Idiopathic Arthritis[J].Phys Occup Ther Pediatr.2022,42(2):187-197.
[3]Gur M, Masarweh K, Toukan Y, et al. Six-minute walk, lung clearance index, and QOL in bronchiolitis obliterans and cystic fibrosis. Pediatric Pulmonology[J].2019,54(4):451-456.
[4]Giuliana Valerio,Maria Rosaria Licenziati,Paola Tortorelli,et al. Lower Performance in the Six-Minute Walk Test in Obese Youth With Cardiometabolic Risk Clustering[J]. Front Endocrinol (Lausanne).2018,9:701.
[5]Donadio MVF, Heinzmann-Filho JP, Vendrusculo FM, et al. Six-minute walk test results predict risk of hospitalization for youths with cystic fibrosis: a 5-year follow-up study[J]. J Pediatr.2017,182:204-209.e1.
[6]Afzal S, Burge AT, Lee AL, et al. Should the 6-minute walk test be stopped if oxyhemoglobin saturation falls below 80% ?[J]. Arch Phys Med Rehabil,2018,99(11):2370-2372.
[7]Dunaway Young S, Montes J, Kramer SS, et al. Six-minute walk test is reliable and valid in spinal muscular atrophy[J].Muscle Nerve.2016,54(5):836-842.
[8]Geiger R,Strasak A,Treml B,et al.Six-minute walk test in children and adolescents[J]. J Pediatr,2007,150(4): 395-399,399.e1-2.
[9]中华医学会心血管病学分会,中国康复医学会心肺预防与康复专业委员会,中华心血管病杂志编辑委员会.六分钟步行试验临床规范应用中国专家共识[J].中华心血管病杂志,2022,50(5):432-442.
[10]Saad HB, Prefaut C, Missaoui R, et al. Reference equation for 6-min walk distance in healthy North African children 6–16 years old [J]. Pediatr Pulmonol. 2009,44(4):316-324.
[11]American Thoracic Society statement:guidelines for the six-minute walk test[J].Am J Respir Crit Care Med. 2002,166:111-117.
[12]Kavgacı A, Kula S, Berber Maraşlı E, et al.Evaluation of handgrip strength in children with pulmonary hypertension[J]. Cardiol Young.2024,page 1-5.
[13]Rosenzweig E, Villeda GAV, Crook S,et al. Efficacy of a commercial physical activity monitor in longitudinal tracking of patients with pulmonary hypertension: a pilot study[J]. Tex Heart Inst J. 2023:50(5):e227866.
[14]Rasekaba T,Lee AL,Naughton MT,et al.The six-minute walk test:a useful metric for the cardiopulmonary patient[J].Intern Med J.2009,39(8):495-501.
[15]杨敏.6 min步行训练在慢性心力衰竭儿童康复护理中的应用[J].全科护理.2018,16(21):2646-2647.
[16]Hunt,SA,Abraham WT,Chin MH,et al.ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure):developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation:endorsed by the Heart Rhythm Society[J].Circulation 2005,112(12):e154-235.
[17]Ruixue Qi,Shijie Liu,Hongjie Wang,et al. Efects of perioperative exercise on cardiorespiratory endurance in children with congenital heart disease in plateau areas after surgical repair[J]. Sci Rep.2023,13(1):18088.
[18]Sandra Nora González-Díaz,Alma Belén Partida-Ortega,Alejandra Macías-Weinmann, et al. Evaluation of functional capacity by 6-minute walk test in children with asthma[J].Rev Alerg Mex.2017,64(4):415-429.
[19]Hansen E S H,Pitzner-Fabricius A,Toennesen L L,et al. Effect of aerobic exercise training on asthma in adults: a systematic review and meta-analysis[J].Eur Respir J,2020,56(1):2000146.
[20]Andrade Lima, C.; Dornelas de Andrade, A.; Campos, S.L.;et al. Six-minute walk test as a determinant of the functional capacity of children and adolescents with cystic fibrosis: A systematic review[J]. Respir. Med. 2018,137:83-88.
[21]Rubinowicz M, Piotrowski R, Nowobilski R. Evaluation of some anthropometric and clinical parameters in children with cystic fibrosis[J]. Pneumonol Alergol Pol. 2005, 73(2):172-177.
[22]Michael Rabbia,Maitea Guridi Ormazabal,Hannah Staunton,et al. Stride Velocity 95th Centile Detects Decline in Ambulatory Function Over Shorter Intervals than the 6-Minute Walk Test or North Star Ambulatory Assessment in Duchenne Muscular Dystrophy[J]. J Neuromuscul Dis.2024,11(3):701-714.
[23]René Günther,Claudia Diana Wurster,Svenja Brakemeier,et al. Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study[J]. Lancet Reg Health Eur.2024,39:100862.
[24]Anna Łusakowska,Adrianna Wójcik,Anna Frączek,et al. Long-term nusinersen treatment across a wide spectrum of spinal muscular atrophy severity: a real-world experience[J]. Orphanet J Rare Dis.2023,18(1):230.
(0 摘要 Views, 0 PDF Downloads)
Refbacks
- 当前没有refback。